封面
市場調查報告書
商品編碼
2177871

精準發酵膠原膠原蛋白市場預測至2034年-全球原料類型、原料形態、應用、銷售管道、最終用戶、生產規模及區域分析

Precision-Fermented Collagen Market Forecasts to 2034 - Global Analysis By Ingredient Types, Ingredient Forms, Applications, Commercialization Channels, End Users, Production Scales, and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 300+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預計到 2026 年,全球精細發酵膠原蛋白市場規模將達到 5 億美元,並在預測期內以 21.0% 的複合年成長率成長,到 2034 年將達到 23 億美元。

微發酵膠原蛋白是指利用基因改造的微生物在發酵過程中表達特定的膠原蛋白序列而產生的膠原蛋白蛋白和胜肽,而非從動物中提取。這些製程可生產I型、II型和III型膠原蛋白、膠原蛋白胜肽前驅物和重組膠原蛋白片段,這些產品能夠複煞車物性膠原蛋白的功能和營養特性。所得原料以粉末、濃縮液、糊狀物、顆粒和冷凍形式供應,可用於食品中的蛋白質強化、糖果甜點的質地調整、飲料配方、肉類替代品的結構構建、營養補充劑和食品塗層。

對非動物性膠原蛋白的需求

消費者對不含動物源成分的膠原蛋白和純素膠原蛋白的需求日益成長,推動了微發酵膠原蛋白的普及。這種膠原蛋白無需使用動物性原料,即可提供同等的胺基酸組成和功能。隨著越來越多的膠原蛋白產品出現在膳食補充劑、飲料和機能性食品中,品牌商正​​在尋找符合純素認證和永續性的原料來源。重組膠原蛋白片段具有穩定的分子量和純度。這種消費者行為的轉變正在已開發市場推動膳食補充劑、飲料和機能性食品管道的溢價和重複購買。

成本和監管複雜性

由於目前生產規模下發酵基礎設施、純化和序列特異性加工成本高昂,微發酵膠原蛋白與動物源膠原膠原蛋白相比仍然價格昂貴。重組膠原膠原蛋白作為食品配料的監管分類因市場而異,有些地區甚至要求將其作為新型食品獲得批准。發酵衍生蛋白的標示要求和消費者接受度仍不明朗。這些成本和監管障礙限制了其早期商業化,使其主要應用於高階膳食補充劑和特殊用途,而非主流食品領域。

在膳食補充劑和飲料市場的定位

營養補充品和機能飲料為精細發酵膠原蛋白生產商提供了絕佳的市場機遇,使其原料能夠應用於對純素和純度要求極高的高價值領域。膠原蛋白肽易於溶於飲料,進而提升其在皮膚、關節和運動營養等領域的市場地位。品牌可以透過獲得不含動物性成分的認證以及生產過程的可追溯性來脫穎而出。隨著市場對膠原蛋白補充劑的需求不斷成長,精細發酵膠原蛋白可以賣出更高的價格,從而贏得注重健康和純素消費者的忠誠。

用動物源性膠原膠原蛋白取代

由於動物源膠原膠原蛋白價格低廉、來源豐富,且為保健品和食品生產商所熟知,消費者不太願意為微發酵替代品支付更高的價格。許多消費者認為動物源膠原膠原蛋白是公認的有效標準。如果發酵膠原蛋白在大規模生產中無法在成本上與動物源膠原膠原蛋白競爭,那麼它的市場可能仍然僅限於素食主義者和注重永續發展的群體。因此,生產商必須證明其替代品在功能上與動物源膠原蛋白相當,且純度更高,才能證明其產品的合理性並為其定價辯護。

新型冠狀病毒(COVID-19)的影響:

疫情擾亂了實驗室准入和初步試驗,延緩了精準發酵膠原膠原蛋白在關鍵研發階段的規模化生產。疫情期間,畜牧業供應鏈中斷以及人們對免疫和皮膚健康的日益關注,推動了對膠原蛋白的需求,並增加了投資者對替代產品的興趣。疫情後,人們對永續性和動物福利的擔憂加速了資金籌措,同時生產商也推動了菌株研發並與監管機構合作。

在預測期內,I 型膠原蛋白細分市場預計將佔據最大的市場佔有率。

鑑於I型膠原蛋白蛋白將佔據最大的市場佔有率。 I型膠原蛋白佔商業性膠原蛋白的大部分,也是微發酵技術開發商的主要目標。隨著生產商擴大I型膠原蛋白的產能,預計該細分市場將繼續保持在整個微發酵膠原膠原蛋白類別中最大的銷售佔有率。

預計在預測期內,「粉末」細分市場將呈現最高的複合年成長率。

在預測期內,粉狀產品預計將呈現最高的成長率,這主要得益於配料商對易於儲存、易於混合且便於添加到膳食補充劑、飲料和食品生產中的配料的需求日益成長。與液體濃縮物相比,粉狀產品重量更輕,儲存時間更長。隨著乾燥效率的提高和溶解度檢驗的改進,用於蛋白質強化和營養補充劑的粉末狀產品上市數量不斷增加,使其成為成長最快的配料形式細分市場。

市佔率最大的地區:

在預測期內,北美預計將佔據最大的市場佔有率,創業融資、強勁的膠原蛋白補充劑市場以及發酵衍生蛋白監管方面的進步。美國正引領區域銷售,這得益於其與開發重組膠原蛋白和補充劑品牌的公司建立的合作關係。對純素膠原膠原蛋白的積極投資和消費者興趣進一步鞏固了該地區的領先地位。

複合年成長率最高的地區:

在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於膠原蛋白補充劑消費量的成長、消費者對純素產品日益成長的興趣,以及中國、日本、韓國和印度等國政府對食品技術創新的支持。當地生產商正在擴大發酵能力,而補充劑品牌則在尋求不含動物源成分的替代品。這些需求促進因素使得亞太地區成為精細發酵膠原膠原蛋白市場成長最快的區域市場。

目標區域:

北美洲

我們

加拿大

墨西哥

歐洲

英國

德國

法國

義大利

西班牙

荷蘭

比利時

瑞典

瑞士

波蘭

其他歐洲國家

亞太地區

中國

日本

印度

韓國

澳洲

印尼

泰國

馬來西亞

新加坡

越南

亞太其他地區

南美洲

巴西

阿根廷

哥倫比亞

智利

秘魯

南美洲其他地區

世界其他地區(RoW)

中東

沙烏地阿拉伯

阿拉伯聯合大公國

卡達

以色列

其他中東國家

非洲

南非

埃及

摩洛哥

其他非洲國家

免費客製化服務:

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項:

企業概況

對其他市場參與者(最多 3 家公司)進行全面分析

對主要公司進行SWOT分析(最多3家公司)

區域細分

根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需進行可行性評估)。

競爭性標竿分析

    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章:全球精細發酵膠原蛋白市場:依原料類型分類

  • I 型膠原蛋白
  • II 型膠原蛋白
  • III型膠原蛋白
  • 膠原蛋白胜肽前驅
  • 重組膠原蛋白片段

第6章:全球精細發酵膠原蛋白市場:依原料形式分類

  • 粉末
  • 濃縮液
  • 貼上
  • 顆粒
  • 冷凍原料

第7章:全球精細發酵膠原蛋白市場:依應用領域分類

  • 食品蛋白質強化
  • 改善糖果甜點的質地
  • 飲料配方
  • 肉類替代品的結構形成
  • 營養補充品
  • 食品塗層

第8章:全球精細發酵膠原蛋白市場:依銷售管道分類

  • 廠商直銷
  • 原物料經銷商
  • B2B市場
  • 契約製造夥伴關係

第9章:全球精準發酵膠原膠原蛋白市場:依最終用戶分類

  • 食品和飲料製造商
  • 原料混合公司
  • 食品契約製造
  • 餐廳經營者
  • 營養補充品製造商
  • 研究與發展研究所

第10章:全球精細發酵膠原蛋白市場:依生產規模分類

  • 實驗室規模
  • 中試規模
  • 商業規模

第11章 全球精細發酵膠原蛋白市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章:公司簡介

  • BASF SE
  • Croda International Plc
  • Evonik Industries AG
  • Symrise AG
  • Givaudan SA
  • DSM-Firmenich AG
  • Ashland Inc
  • Clariant AG
  • Kerry Group plc
  • International Flavors & Fragrances Inc
  • Lonza Group AG
  • Solvay SA
  • Lubrizol Corporation
  • Seppic SA
  • Lucas Meyer Cosmetics
  • and Nouryon Holding BV
Product Code: SMRC41547

According to Stratistics MRC, the Global Precision-Fermented Collagen Market is accounted for $0.5 billion in 2026 and is expected to reach $2.3 billion by 2034 growing at a CAGR of 21.0% during the forecast period. Precision-fermented collagen refers to collagen proteins and peptides produced by engineered microorganisms that express specific collagen sequences during fermentation rather than through animal extraction. These processes generate Type I, Type II, and Type III collagen, collagen peptide precursors, and recombinant collagen fragments that replicate the functional and nutritional properties of animal-derived collagen. The resulting ingredients are supplied as powders, liquid concentrates, pastes, granules, and frozen forms for food protein fortification, confectionery texturization, beverage formulation, meat alternative structuring, nutritional supplements, and edible coatings.

Market Dynamics:

Driver:

Animal-Free Collagen Demand

Growing consumer preference for animal-free and vegan collagen is driving adoption of precision-fermented collagen that delivers the same amino acid profile and functionality without animal inputs. Supplements, beverages, and functional foods increasingly feature collagen claims, and brands seek sources that satisfy vegan certification and sustainability commitments. Recombinant collagen fragments offer consistent molecular weight and purity. This behavioral shift supports premium pricing and repeat purchase across supplements, beverages, and functional food channels in developed markets.

Restraint:

Cost and Regulatory Complexity

Precision-fermented collagen remains expensive relative to animal-derived collagen, because fermentation infrastructure, purification, and sequence-specific processing costs are high at current scales. Regulatory classification of recombinant collagen as a food ingredient varies across markets, with some jurisdictions requiring novel food authorization. Labeling requirements and consumer acceptance of fermentation-derived proteins remain uncertain. These cost and regulatory barriers confine early commercialization to premium supplements and specialty applications rather than mainstream food categories.

Opportunity:

Supplement and Beverage Positioning

Nutritional supplements and functional beverages create substantial opportunity for precision-fermented collagen producers to position ingredients in high-value applications where vegan claims and purity matter. Collagen peptides dissolve readily in beverages and support skin, joint, and sports nutrition positioning. Brands can differentiate through animal-free certification and traceable production. As collagen supplement demand grows, precision-fermented collagen can capture premium pricing and build loyalty across health-focused and vegan consumer segments.

Threat:

Substitution by Animal-Derived Collagen

Animal-derived collagen remains inexpensive, abundant, and familiar to supplement and food manufacturers, which reduces willingness to pay premiums for precision-fermented alternatives. Many consumers perceive animal collagen as the established standard for efficacy. If fermentation-derived collagen cannot match cost at scale, adoption may remain confined to vegan and sustainability-driven segments. Consequently, producers must demonstrate functional equivalence and purity advantages to justify substitution and defend pricing.

Covid-19 Impact:

The pandemic disrupted laboratory access and pilot trials, delaying precision-fermented collagen scale-up during a critical development phase. During the crisis, supply chain disruptions in animal agriculture and heightened interest in immune and skin health supported collagen demand and strengthened investor interest in alternatives. Post-pandemic, renewed focus on sustainability and animal welfare has accelerated funding, while producers advanced strain development and regulatory engagement.

The Type I Collagen segment is expected to be the largest during the forecast period

The Type I Collagen segment is expected to account for the largest market share during the forecast period, due to its dominant role in skin, bone, and connective tissue applications and its established consumer recognition in supplement and beverage markets. Type I collagen accounts for the majority of commercially used collagen and is the primary target for precision fermentation developers. As producers scale Type I capacity, this segment sustains leading revenue share across the precision-fermented collagen category.

The Powders segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Powders segment is predicted to witness the highest growth rate, driven by formulator preference for shelf-stable, easily blended ingredients that integrate into supplement, beverage, and food manufacturing. Powders reduce transport weight and support long shelf life compared with liquid concentrates. As drying efficiency improves and dissolution performance is validated, powder launches multiply across protein fortification and nutritional supplement applications, making this the fastest-growing ingredient form segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to concentrated venture funding for precision fermentation startups, strong collagen supplement market, and regulatory progress on fermentation-derived proteins. The United States dominates regional revenue, supported by companies developing recombinant collagen and partnerships with supplement brands. Active investment and consumer interest in vegan collagen further reinforce the region's leading position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding collagen supplement consumption, rising interest in vegan products, and government support for food technology innovation across China, Japan, South Korea, and India. Local producers are scaling fermentation capacity, while supplement brands seek animal-free alternatives. These demand catalysts make Asia Pacific the fastest-growing regional market for precision-fermented collagen.

Key players in the market

Some of the key players in Precision-Fermented Collagen Market include BASF SE, Croda International Plc, Evonik Industries AG, Symrise AG, Givaudan SA, DSM-Firmenich AG, Ashland Inc., Clariant AG, Kerry Group plc, International Flavors & Fragrances Inc., Lonza Group AG, Solvay SA, Lubrizol Corporation, Seppic S.A., Lucas Meyer Cosmetics, and Nouryon Holding B.V.

Key Developments:

In October 2026, DSM-Firmenich AG launched a precision-fermented Type I collagen powder for supplement and beverage applications, supported by amino acid profiling and distributed through direct manufacturer sales and business-to-business marketplaces across European and North American markets.

In September 2026, Kerry Group plc expanded its precision-fermented collagen portfolio with Type II and Type III concentrates positioned for nutritional supplements, targeting nutraceutical manufacturers through ingredient distributors and contract manufacturing partnerships.

In August 2026, Evonik Industries AG introduced recombinant collagen fragments and peptide precursors formulated for beverage formulation and edible coatings, distributed through direct sales and technology licensing partnerships across Asia Pacific food processing markets.

Ingredient Types Covered:

  • Type I Collagen
  • Type II Collagen
  • Type III Collagen
  • Collagen Peptide Precursors
  • Recombinant Collagen Fragments

Ingredient Forms Covered:

  • Powders
  • Liquid Concentrates
  • Pastes
  • Granules
  • Frozen Ingredients

Applications Covered:

  • Food Protein Fortification
  • Confectionery Texturization
  • Beverage Formulation
  • Meat Alternative Structuring
  • Nutritional Supplements
  • Edible Coatings

Commercialization Channels Covered:

  • Direct Manufacturer Sales
  • Ingredient Distributors
  • Business-to-Business Marketplaces
  • Contract Manufacturing Partnerships

End Users Covered:

  • Food and Beverage Manufacturers
  • Ingredient Blenders
  • Contract Food Manufacturers
  • Foodservice Operators
  • Nutraceutical Manufacturers
  • Research and Development Laboratories

Production Scales Covered:

  • Laboratory Scale
  • Pilot Scale
  • Commercial Scale

Regions Covered:

North America

United States

Canada

Mexico

Europe

United Kingdom

Germany

France

Italy

Spain

Netherlands

Belgium

Sweden

Switzerland

Poland

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Thailand

Malaysia

Singapore

Vietnam

Rest of Asia Pacific

South America

Brazil

Argentina

Colombia

Chile

Peru

Rest of South America

Rest of the World (RoW)

Middle East

Saudi Arabia

United Arab Emirates

Qatar

Israel

Rest of Middle East

Africa

South Africa

Egypt

Morocco

Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling

Comprehensive profiling of additional market players (up to 3)

SWOT Analysis of key players (up to 3)

Regional Segmentation

Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)

Competitive Benchmarking

    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Precision-Fermented Collagen Market, By Ingredient Types

  • 5.1 Type I Collagen
  • 5.2 Type II Collagen
  • 5.3 Type III Collagen
  • 5.4 Collagen Peptide Precursors
  • 5.5 Recombinant Collagen Fragments

6 Global Precision-Fermented Collagen Market, By Ingredient Forms

  • 6.1 Powders
  • 6.2 Liquid Concentrates
  • 6.3 Pastes
  • 6.4 Granules
  • 6.5 Frozen Ingredients

7 Global Precision-Fermented Collagen Market, By Applications

  • 7.1 Food Protein Fortification
  • 7.2 Confectionery Texturization
  • 7.3 Beverage Formulation
  • 7.4 Meat Alternative Structuring
  • 7.5 Nutritional Supplements
  • 7.6 Edible Coatings

8 Global Precision-Fermented Collagen Market, By Commercialization Channels

  • 8.1 Direct Manufacturer Sales
  • 8.2 Ingredient Distributors
  • 8.3 Business-to-Business Marketplaces
  • 8.4 Contract Manufacturing Partnerships

9 Global Precision-Fermented Collagen Market, By End Users

  • 9.1 Food and Beverage Manufacturers
  • 9.2 Ingredient Blenders
  • 9.3 Contract Food Manufacturers
  • 9.4 Foodservice Operators
  • 9.5 Nutraceutical Manufacturers
  • 9.6 Research and Development Laboratories

10 Global Precision-Fermented Collagen Market, By Production Scales

  • 10.1 Laboratory Scale
  • 10.2 Pilot Scale
  • 10.3 Commercial Scale

11 Global Precision-Fermented Collagen Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiling

  • 14.1 BASF SE
  • 14.2 Croda International Plc
  • 14.3 Evonik Industries AG
  • 14.4 Symrise AG
  • 14.5 Givaudan SA
  • 14.6 DSM-Firmenich AG
  • 14.7 Ashland Inc
  • 14.8 Clariant AG
  • 14.9 Kerry Group plc
  • 14.10 International Flavors & Fragrances Inc
  • 14.11 Lonza Group AG
  • 14.12 Solvay SA
  • 14.13 Lubrizol Corporation
  • 14.14 Seppic S.A
  • 14.15 Lucas Meyer Cosmetics
  • 14.16 and Nouryon Holding B.V

List of Tables

  • Table 1 Global Precision-Fermented Collagen Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Precision-Fermented Collagen Market Outlook, By Ingredient Types (2023-2034) ($MN)
  • Table 3 Global Precision-Fermented Collagen Market Outlook, By Type I Collagen (2023-2034) ($MN)
  • Table 4 Global Precision-Fermented Collagen Market Outlook, By Type II Collagen (2023-2034) ($MN)
  • Table 5 Global Precision-Fermented Collagen Market Outlook, By Type III Collagen (2023-2034) ($MN)
  • Table 6 Global Precision-Fermented Collagen Market Outlook, By Collagen Peptide Precursors (2023-2034) ($MN)
  • Table 7 Global Precision-Fermented Collagen Market Outlook, By Recombinant Collagen Fragments (2023-2034) ($MN)
  • Table 8 Global Precision-Fermented Collagen Market Outlook, By Ingredient Forms (2023-2034) ($MN)
  • Table 9 Global Precision-Fermented Collagen Market Outlook, By Powders (2023-2034) ($MN)
  • Table 10 Global Precision-Fermented Collagen Market Outlook, By Liquid Concentrates (2023-2034) ($MN)
  • Table 11 Global Precision-Fermented Collagen Market Outlook, By Pastes (2023-2034) ($MN)
  • Table 12 Global Precision-Fermented Collagen Market Outlook, By Granules (2023-2034) ($MN)
  • Table 13 Global Precision-Fermented Collagen Market Outlook, By Frozen Ingredients (2023-2034) ($MN)
  • Table 14 Global Precision-Fermented Collagen Market Outlook, By Applications (2023-2034) ($MN)
  • Table 15 Global Precision-Fermented Collagen Market Outlook, By Food Protein Fortification (2023-2034) ($MN)
  • Table 16 Global Precision-Fermented Collagen Market Outlook, By Confectionery Texturization (2023-2034) ($MN)
  • Table 17 Global Precision-Fermented Collagen Market Outlook, By Beverage Formulation (2023-2034) ($MN)
  • Table 18 Global Precision-Fermented Collagen Market Outlook, By Meat Alternative Structuring (2023-2034) ($MN)
  • Table 19 Global Precision-Fermented Collagen Market Outlook, By Nutritional Supplements (2023-2034) ($MN)
  • Table 20 Global Precision-Fermented Collagen Market Outlook, By Edible Coatings (2023-2034) ($MN)
  • Table 21 Global Precision-Fermented Collagen Market Outlook, By Commercialization Channels (2023-2034) ($MN)
  • Table 22 Global Precision-Fermented Collagen Market Outlook, By Direct Manufacturer Sales (2023-2034) ($MN)
  • Table 23 Global Precision-Fermented Collagen Market Outlook, By Ingredient Distributors (2023-2034) ($MN)
  • Table 24 Global Precision-Fermented Collagen Market Outlook, By Business-to-Business Marketplaces (2023-2034) ($MN)
  • Table 25 Global Precision-Fermented Collagen Market Outlook, By Contract Manufacturing Partnerships (2023-2034) ($MN)
  • Table 26 Global Precision-Fermented Collagen Market Outlook, By End Users (2023-2034) ($MN)
  • Table 27 Global Precision-Fermented Collagen Market Outlook, By Food and Beverage Manufacturers (2023-2034) ($MN)
  • Table 28 Global Precision-Fermented Collagen Market Outlook, By Ingredient Blenders (2023-2034) ($MN)
  • Table 29 Global Precision-Fermented Collagen Market Outlook, By Contract Food Manufacturers (2023-2034) ($MN)
  • Table 30 Global Precision-Fermented Collagen Market Outlook, By Foodservice Operators (2023-2034) ($MN)
  • Table 31 Global Precision-Fermented Collagen Market Outlook, By Nutraceutical Manufacturers (2023-2034) ($MN)
  • Table 32 Global Precision-Fermented Collagen Market Outlook, By Research and Development Laboratories (2023-2034) ($MN)
  • Table 33 Global Precision-Fermented Collagen Market Outlook, By Production Scales (2023-2034) ($MN)
  • Table 34 Global Precision-Fermented Collagen Market Outlook, By Laboratory Scale (2023-2034) ($MN)
  • Table 35 Global Precision-Fermented Collagen Market Outlook, By Pilot Scale (2023-2034) ($MN)
  • Table 36 Global Precision-Fermented Collagen Market Outlook, By Commercial Scale (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.